JP2023553938A5 - - Google Patents
Info
- Publication number
- JP2023553938A5 JP2023553938A5 JP2023535346A JP2023535346A JP2023553938A5 JP 2023553938 A5 JP2023553938 A5 JP 2023553938A5 JP 2023535346 A JP2023535346 A JP 2023535346A JP 2023535346 A JP2023535346 A JP 2023535346A JP 2023553938 A5 JP2023553938 A5 JP 2023553938A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- antibody
- sfrp2
- humanized anti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124345P | 2020-12-11 | 2020-12-11 | |
| US63/124,345 | 2020-12-11 | ||
| PCT/US2021/062854 WO2022125927A1 (en) | 2020-12-11 | 2021-12-10 | Compositions and methods comprising sfrp2 antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023553938A JP2023553938A (ja) | 2023-12-26 |
| JP2023553938A5 true JP2023553938A5 (https=) | 2024-12-18 |
| JP7747350B2 JP7747350B2 (ja) | 2025-10-01 |
Family
ID=81974701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535346A Active JP7747350B2 (ja) | 2020-12-11 | 2021-12-10 | Ｓｆｒｐ２アンタゴニストを含む組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11873333B2 (https=) |
| EP (1) | EP4259203A4 (https=) |
| JP (1) | JP7747350B2 (https=) |
| KR (1) | KR102934264B1 (https=) |
| CN (1) | CN116744970A (https=) |
| AU (1) | AU2021396381A1 (https=) |
| CA (1) | CA3201893A1 (https=) |
| IL (1) | IL303600A (https=) |
| MX (1) | MX2023006777A (https=) |
| WO (1) | WO2022125927A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102934264B1 (ko) | 2020-12-11 | 2026-03-05 | 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 | Sfrp2 길항제를 포함하는 조성물 및 방법 |
| WO2025076318A1 (en) * | 2023-10-06 | 2025-04-10 | Musc Foundation For Research Development | Compositions for modulating the kras pathway and methods of use thereof |
| CN117756910A (zh) * | 2023-12-22 | 2024-03-26 | 首都医科大学附属北京口腔医院 | Sfrp2功能多肽及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| EP0216846B2 (en) | 1985-04-01 | 1995-04-26 | Celltech Limited | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| MX9204374A (es) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
| US6174666B1 (en) | 1992-03-27 | 2001-01-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of eliminating inhibitory/instability regions from mRNA |
| US20040014194A1 (en) | 2002-03-27 | 2004-01-22 | Schering Corporation | Beta-secretase crystals and methods for preparing and using the same |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| EP3124497B1 (en) | 2007-09-14 | 2020-04-15 | Adimab, LLC | Rationally designed, synthetic antibody libraries and uses therefor |
| JP2011523551A (ja) | 2008-05-15 | 2011-08-18 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 血管形成の調節の新規ターゲット |
| WO2011119524A1 (en) | 2010-03-22 | 2011-09-29 | The University Of North Carolina At Chapel Hill | Novel targets for regulation of angiogenesis |
| KR102318383B1 (ko) | 2010-07-16 | 2021-10-27 | 아디맵 엘엘씨 | 항체 라이브러리 |
| JP6072771B2 (ja) | 2011-04-20 | 2017-02-01 | メディミューン，エルエルシー | Ｂ７−ｈ１およびｐｄ−１に結合する抗体およびその他の分子 |
| WO2015038882A1 (en) * | 2013-09-13 | 2015-03-19 | The University Of North Carolina At Chapel Hill | Methods and compositions for tumor vasculature imaging and targeted therapy |
| KR102934264B1 (ko) | 2020-12-11 | 2026-03-05 | 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 | Sfrp2 길항제를 포함하는 조성물 및 방법 |
-
2021
- 2021-12-10 KR KR1020237022926A patent/KR102934264B1/ko active Active
- 2021-12-10 JP JP2023535346A patent/JP7747350B2/ja active Active
- 2021-12-10 IL IL303600A patent/IL303600A/en unknown
- 2021-12-10 WO PCT/US2021/062854 patent/WO2022125927A1/en not_active Ceased
- 2021-12-10 CN CN202180090221.0A patent/CN116744970A/zh active Pending
- 2021-12-10 US US17/547,550 patent/US11873333B2/en active Active
- 2021-12-10 AU AU2021396381A patent/AU2021396381A1/en active Pending
- 2021-12-10 CA CA3201893A patent/CA3201893A1/en active Pending
- 2021-12-10 EP EP21904485.6A patent/EP4259203A4/en active Pending
- 2021-12-10 MX MX2023006777A patent/MX2023006777A/es unknown
-
2024
- 2024-01-12 US US18/412,245 patent/US12258388B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512132A5 (https=) | ||
| JP2023553938A5 (https=) | ||
| AU2017328309B2 (en) | Antibody specifically binding to PD-1 and functional fragment thereof | |
| JP2018502050A5 (https=) | ||
| IL272349B1 (en) | Anti-cd137 antibodies | |
| JP2017149720A5 (https=) | ||
| JP2023543031A5 (https=) | ||
| JP2024105229A5 (https=) | ||
| JP2011207882A5 (https=) | ||
| JP2010509931A5 (https=) | ||
| JP2025500971A5 (https=) | ||
| TWI797609B (zh) | 抗pd-1和pd-l1的四價雙特異性抗體 | |
| JP2021530244A5 (https=) | ||
| CN113943371B (zh) | 一种抗her2/抗pd-l1双功能抗体及其应用 | |
| FI4200018T3 (fi) | Anti-par-2-vasta-aineet ja niiden käyttömenetelmät | |
| KR20230132544A (ko) | 신규한 항-그렘린1 항체 | |
| CN120936630A (zh) | Dll3抗体-药物缀合物和其用途 | |
| EP4667491A1 (en) | Anti-cntn4 antibody and uses thereof | |
| CN110835372B (zh) | 一种靶向Frizzled7单克隆抗体及其制备方法与应用 | |
| RU2023117779A (ru) | Композиции и способы, содержащие антагонисты sfrp2 | |
| JP2024528987A5 (https=) | ||
| CN115505041B (en) | Anti-EphA 2 antibodies and uses thereof | |
| CN110407942B (zh) | 针对kn044的单域抗体 | |
| WO2025172588A1 (en) | Bispecific constructs directed against fap and ltbr | |
| RU2024108736A (ru) | Биспецифическое антитело к lag3, фармацевтическая композиция и применение |